Evidence-Based Medicine Guidelines
Gastrointestinal safety profile of meloxicam
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Gastrointestinal Safety Profile of Meloxicam." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456149/all/Gastrointestinal_safety_profile_of_meloxicam.
Gastrointestinal safety profile of meloxicam. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/456149/all/Gastrointestinal_safety_profile_of_meloxicam. Accessed May 17, 2025.
Gastrointestinal safety profile of meloxicam. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/456149/all/Gastrointestinal_safety_profile_of_meloxicam
Gastrointestinal Safety Profile of Meloxicam [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 May 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456149/all/Gastrointestinal_safety_profile_of_meloxicam.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Gastrointestinal safety profile of meloxicam
ID - 456149
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456149/all/Gastrointestinal_safety_profile_of_meloxicam
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
